Ascendis Pharma AS (A71) — Strategic Asset Allocation Index
Ascendis Pharma AS (A71) has a Strategic Asset Allocation Index of 4.8% as of March 2026. Strategic assets (PP&E of €- plus long-term investments of €23.56 Million) total €23.56 Million, measured against net assets of €487.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See A71 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Ascendis Pharma AS Strategic Asset Allocation Index (2016–2022)
This chart shows how Ascendis Pharma AS's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of March 2026, the index stands at 4.8%, representing strategic assets of €23.56 Million against net assets of €487.97 Million EUR. For live market cap and overall valuation, see Ascendis Pharma AS (A71) market capitalisation.
Annual Strategic Asset Allocation Index for Ascendis Pharma AS (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ascendis Pharma AS from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Ascendis Pharma AS net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.6% | €30.42 Million | €- | €30.42 Million | €263.35 Million | ▼ -19.2 pp |
| 2021 | 30.8% | €271.95 Million | €126.05 Million | €145.91 Million | €883.63 Million | ▲ +3.0 pp |
| 2020 | 27.7% | €232.57 Million | €108.11 Million | €124.46 Million | €838.71 Million | ▲ +17.6 pp |
| 2019 | 10.1% | €60.61 Million | €45.07 Million | €15.54 Million | €597.11 Million | ▲ +2.5 pp |
| 2018 | 7.6% | €21.41 Million | €4.33 Million | €17.08 Million | €280.05 Million | ▲ +6.3 pp |
| 2017 | 1.4% | €2.56 Million | €2.56 Million | €0.00 | €187.21 Million | ▲ +0.0 pp |
| 2016 | 1.3% | €2.35 Million | €2.35 Million | €- | €176.61 Million | — |